Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. The Company offer patients and physicians the broadest access to diagnostic testing services through its network of laboratories and owned patient service centers, and interpretive consultation.... more

AmeriPath is one of the nation's leading providers of anatomic pathology and molecular diagnostics. Our team of subspecialized pathologists and Ph.D-level scientists provides an unparalleled level of medical expertise, diagnostic quality and personal consultation services. Moreover, our... more

Matritech is using its patented proteomics technology to develop diagnostics for the detection of a variety of cancers. The Company's first two products, the NMP22® Test Kit and NMP22® BladderChek® Test, have been approved for both the monitoring and diagnosis of bladder cancer. The NMP22... more

Xenomics, Inc. is the developer of next-generation molecular diagnostics products that address important health problems worldwide. Our mission is to apply our proprietary transrenal DNA test platform to develop highly sensitive, truly non-invasive molecular diagnostics that replace... more

DiagnoCure Inc. (DiagnoCure) is a biotechnology company commercializing cancer diagnostic tests and delivering lab services. The Company specializes in the development of cancer diagnostic assays incorporating molecular markers. As of October 31, 2007, DiagnoCure had three wholly owned... more

Clarient, Inc. (Clarient) is a cancer diagnostic company providing cellular assessment and cancer characterization to three customer groups: community pathologists, academic researchers and university hospitals, and biopharmaceutical companies. Clarient is engaged in delivering critical... more

TriPath develops, manufactures, markets, and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging, and treatment. TriPath was formed in September 1999 through the merger of AutoCyte, Inc. and NeoPath, Inc. and acquisition of... more

DakoCytomation produces a wide array of biochemical products used by health care professionals and researchers around the world for diagnostic and research purposes. The nature of our products and business areas may be difficult to assess without a specific scientific background, and it... more

Dako is a global leader in tissue-based cancer diagnostics. Dako provides reagents, instruments and software for high quality cancer diagnosis and efficient laboratory processes. Fast, accurate test results are crucial when a patient is possibly faced with a disease. Cancer diagnostics... more

Oncotech, Inc., based in Tustin, California, is an innovative oncology company, which provides state of the art molecular oncology laboratory services to assist physicians in the care and management of their cancer patients. To date, Oncotech Clinical Laboratory Division has performed... more

Ipsogen SA is a France-based company engaged in the development, manufacturing and marketing of diagnostic tests. It offers a range of molecular tests to profile breast cancer and leukemia and provide guidance in diagnostics. Ipsogen SA sells its products to reference centers for cancer... more

Irvine-based US LABS is a national, anatomic pathology reference laboratory devoted to comprehensive, high quality, rapid response cancer testing. The company provides diagnostic, prognostic, and predictive cancer testing services to hospitals, physician offices, surgery centers, and... more

IMPATH Inc. (Nasdaq: IMPH) is in the business of improving outcomes for cancer patients. The Company is the leading source of cancer information and analyses with a database of more than 800,000 analyzed cases to date. IMPATH uses sophisticated technologies to provide patient-specific... more

NeoGenomics, Inc. (NeoGenomics) operates a network of cancer-focused testing laboratories. The Company offers testing services to pathologists, oncologists, urologists, hospitals and other laboratories throughout the United States, such as cytogenetics testing, which analyzes human... more

Perceptronix Medical Inc. is a privately owned, cancer diagnostics company based in Vancouver, Canada. The company was founded in 1999 to commercialize innovative cancer diagnosis technologies developed in partnership with the BC Cancer Agency, a renowned cancer research and treatment... more

Fujirebio Diagnostics, Inc. is a world leader in the production of in vitro diagnostics, and biomarkers. The name Fujirebio (pronounced Fuji-Ray-Bee-Oh) symbolizes restoration of health. Our parent company, Fujirebio, Inc., a leading healthcare company in Japan with a focus on... more

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in the U.S. On November 10, 1992, the Company licensed a patent for the detection of cancers... more

Agendia has developed high-quality diagnostic methods using microarray gene expression profiling to determine the tumor's specific properties: MammaPrint® can reliably predict whether an individual breast cancer patient is at high or low risk of disease recurrence. In addition, Agendia... more

Exagen's unique technology enables us to queue up multiple, high-quality products for our licensing partners within two to three years. For more information about Exagen's capabilities in this area, please contact: Public Relations at Exagen Diagnostics, Inc.... more

Medical Solutions is a leading provider of expert, quality services and products to the healthcare, pharma biotech and life science research sectors. Medical Solutions has an unparallelled combination of expertise in diagnostic pathology, cytology and genomics. This places Medical... more

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient's tumor. Our tests improve the classification of cancer, support... more

We are dedicated to present options and deliver solutions that work. We take the time to research and identify the needs of each client to ensure delivery of innovative promotional media. CX Designs was created out of the increasing need for small businesses and non-profit... more

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians and patients with high-value in vitro diagnostic oncology products.Veridex's products will significantly benefit patients through earlier disease detection, and will enable personalized... more

Zymed Laboratories, Inc. is an integrated, technology-driven, immunoassay reagent company based in South San Francisco, CA. Zymed serves 2 primary segments: life sciences research and clinical diagnostics. Our product portfolio reflects Zymed's strategy of being a value-added,... more

RedPath offers exciting career opportunities for smart, focused, talented team players who have excellent domain-specific expertise (medical, technical, sales, administrative, etc.). With clear Corporate Vision and Core Values, we're creating a positive, innovative and collaborative place... more

Founded in 2004 in Santa Barbara, California, Celerus Diagnostics is committed to enhancing the diagnostic capabilities of the pathology laboratory. Celerus technology provides the capability to decentralize testing, and move results closer to the patient for real time decision making.

mtm laboratories AG, founded in 1999, is a privately held company based in Heidelberg, Germany, specialised in the development of products for the early detection, diagnosis and prevention of cancer. mtm's first line of products, CINtec (TM) assays, are currently in clinical trials for... more

Tessera, Inc is a Seattle-based, biotechnology company dedicated to developing new, cutting-edge diagnostic products for the early detection of prostate and colon cancers. The company was incorporated in Washington State in 2000. Using new, patented technology discovered by leading... more

ONCONIX is a cancer diagnostics Development Company focused on the identification of promising diagnostic tests that, having completed research and development, are poised for commercialization. ONCONIX seeks to establish a strong intellectual property position by direct licensing or... more

Oncose, Inc. is an emerging market leader in cancer detection, diagnosis and treatment using proprietary technology to detect structural changes in glycoproteins that occur during oncogenesis. Glycoproteins are protein molecules with sugars (glycans) attached that are often found on cell... more

Oncology Research Therapeutics is dedicated to providing and discovering breakthrough cancer diagnostics that will dramatically improve the lives of patients suffering from a wide array of cancers. We also provide R&D services that will improve drug development for the Biotech and... more